- Home
- CLPT
as 07-26-2024 4:00pm EST
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | SOLANA BEACH |
| Market Cap: | 146.2M | IPO Year: | N/A |
| Target Price: | $12.00 | AVG Volume (30 days): | 341.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.83 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.05 - $7.97 | Next Earning Date: | 08-07-2024 |
| Revenue: | $26,161,000 | Revenue Growth: | 24.86% |
| Revenue Growth (this year): | 29.95% | Revenue Growth (next year): | 38.34% |
Latest ClearPoint Neuro Inc. News
CLPT Breaking Stock News: Dive into CLPT Ticker-Specific Updates for Smart Investing
GlobeNewswire
9 days ago
ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024
GlobeNewswire
a month ago
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial
PR Newswire
a month ago
Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons
GlobeNewswire
2 months ago
ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System
GuruFocus.com
3 months ago
ClearPoint Neuro Inc (CLPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth ...
GlobeNewswire
3 months ago
ClearPoint Neuro Reports First Quarter 2024 Results
GlobeNewswire
3 months ago
ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore
GlobeNewswire
3 months ago
ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory
Compare CLPT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CLPT ClearPoint Neuro Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.